Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Galectin-1 and immunotherapy for brain cancer.
Verschuere T, De Vleeschouwer S, Lefranc F, Kiss R, Van Gool SW. Verschuere T, et al. Expert Rev Neurother. 2011 Apr;11(4):533-43. doi: 10.1586/ern.11.40. Expert Rev Neurother. 2011. PMID: 21469926 Review.
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T, Toelen J, Maes W, Poirier F, Boon L, Tousseyn T, Mathivet T, Gerhardt H, Mathieu V, Kiss R, Lefranc F, Van Gool SW, De Vleeschouwer S. Verschuere T, et al. Int J Cancer. 2014 Feb 15;134(4):873-84. doi: 10.1002/ijc.28426. Epub 2013 Sep 4. Int J Cancer. 2014. PMID: 23929302
Dendritic cell therapy of high-grade gliomas.
Van Gool S, Maes W, Ardon H, Verschuere T, Van Cauter S, De Vleeschouwer S. Van Gool S, et al. Among authors: verschuere t. Brain Pathol. 2009 Oct;19(4):694-712. doi: 10.1111/j.1750-3639.2009.00316.x. Brain Pathol. 2009. PMID: 19744041 Free PMC article. Review.
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.
Ardon H, Van Gool SW, Verschuere T, Maes W, Fieuws S, Sciot R, Wilms G, Demaerel P, Goffin J, Van Calenbergh F, Menten J, Clement P, Debiec-Rychter M, De Vleeschouwer S. Ardon H, et al. Among authors: verschuere t. Cancer Immunol Immunother. 2012 Nov;61(11):2033-44. doi: 10.1007/s00262-012-1261-1. Epub 2012 Apr 22. Cancer Immunol Immunother. 2012. PMID: 22527250 Free PMC article. Clinical Trial.
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma.
Vandenberk L, Garg AD, Verschuere T, Koks C, Belmans J, Beullens M, Agostinis P, De Vleeschouwer S, Van Gool SW. Vandenberk L, et al. Among authors: verschuere t. Oncoimmunology. 2015 Sep 11;5(2):e1083669. doi: 10.1080/2162402X.2015.1083669. eCollection 2016 Feb. Oncoimmunology. 2015. PMID: 27057467 Free PMC article.
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth.
Mathivet T, Bouleti C, Van Woensel M, Stanchi F, Verschuere T, Phng LK, Dejaegher J, Balcer M, Matsumoto K, Georgieva PB, Belmans J, Sciot R, Stockmann C, Mazzone M, De Vleeschouwer S, Gerhardt H. Mathivet T, et al. Among authors: verschuere t. EMBO Mol Med. 2017 Dec;9(12):1629-1645. doi: 10.15252/emmm.201607445. EMBO Mol Med. 2017. PMID: 29038312 Free PMC article.
Galectin-1 in melanoma biology and related neo-angiogenesis processes.
Mathieu V, de Lassalle EM, Toelen J, Mohr T, Bellahcène A, Van Goietsenoven G, Verschuere T, Bouzin C, Debyser Z, De Vleeschouwer S, Van Gool S, Poirier F, Castronovo V, Kiss R, Feron O. Mathieu V, et al. Among authors: verschuere t. J Invest Dermatol. 2012 Sep;132(9):2245-54. doi: 10.1038/jid.2012.142. Epub 2012 May 24. J Invest Dermatol. 2012. PMID: 22622427 Free article.
18 results